Otros idiomas Granules India Limited

Acciones

GRANULES

INE101D01020

Mercado cerrado - Bombay S.E. Otros sitios de cotización 12:00:50 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
423,4 ^INR	-0,38 %		+1,38 %	+4,43 %

30/04	La filial de Granules Pharmaceuticals obtiene la aprobación de la FDA estadounidense para un medicamento genérico contra las crisis de gota	MT
03/04	La unidad de Granules India obtiene el estatus VAI para su planta de Virginia	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Granules India : ANDA Approval for Colchicine Capsules 0.6 mg	30/04
Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares	30/04
Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	15/04
Granules India Unit Gets VAI Status for Virginia Facility	03/04
Granules India Limited Announces Appointment of Directors	02/04
Granules India Limited Announces Cessation of Arun Rao Akinepally as Independent Director	29/03
Granules India Limited Announces Appointment of Sethu Madhavan Sankaran as Senior Vice President - Api Manufacturing & Operations	29/03
Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer	11/03
Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing	05/03
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	23/01
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	18/12
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	13/12
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	13/12
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension	04/12
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Granules India : Received ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	19/10/23
Granules India Gets US FDA's Approval for Generic Drug for GERD Symptoms	19/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Granules India Limited

Acciones

GRANULES

INE101D01020

Otros idiomas

Filtros